PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 56 filers reported holding PROQR THRAPEUTICS N V in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 208 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 208 | -98.9% | 0.00% | – |
| Q1 2022 | $17,000 | -83.7% | 18,877 | +45.0% | 0.00% | -100.0% |
| Q4 2021 | $104,000 | +16.9% | 13,017 | +22.1% | 0.00% | 0.0% |
| Q3 2021 | $89,000 | +8800.0% | 10,665 | +4235.4% | 0.00% | – |
| Q3 2020 | $1,000 | -96.9% | 246 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $32,000 | +3100.0% | 246 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 246 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 246 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 246 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 246 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -50.0% | 246 | -29.7% | 0.00% | – |
| Q4 2018 | $6,000 | – | 350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,922,570 | $19,053,000 | 7.16% |
| DAFNA Capital Management LLC | 1,114,000 | $11,040,000 | 3.79% |
| RTW INVESTMENTS, LP | 4,779,135 | $47,361,000 | 1.79% |
| Kerrisdale Advisers, LLC | 448,880 | $4,448,000 | 1.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 805,000 | $7,978,000 | 0.66% |
| Artal Group S.A. | 1,300,000 | $12,883,000 | 0.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,571,319 | $45,302,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $2,194,000 | 0.09% |
| COWEN AND COMPANY, LLC | 103,727 | $1,028,000 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $595,000 | 0.07% |